The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: The ultimate dilemma

Journal of the American College of Cardiology

Volumn 63, Issue 1, 2014, Pages 12-14

  Fogel, Richard I ^a   Epstein, Andrew E ^b   Mark Estes, N A ^c   Lindsay, Bruce D ^d   Dimarco, John P ^e   Kremers, Mark S ^f   Kapa, Suraj ^b   Brindis, Ralph G ^g   Russo, Andrea M ^h  

^a St Vincent Medical Group   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f Novant Heart Vascular Institute   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Appropriate Use Criteria; guidelines; implantable cardioverter defibrillator; National Coverage Determination

Indexed keywords

APPROPRIATE USE CRITERIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; EVIDENCE BASED MEDICINE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INSURANCE; LEGAL LIABILITY; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; HEALTH CARE CONCEPTS; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; SHORT SURVEY;

ACC; AHA; AMERICAN COLLEGE OF CARDIOLOGY; AMERICAN HEART ASSOCIATION; APPROPRIATE USE CRITERIA; AUC; CARDIAC RESYNCHRONIZATION THERAPY; CRT; DEPARTMENT OF JUSTICE; DOJ; GUIDELINES; HEART RHYTHM SOCIETY; HRS; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; NATIONAL COVERAGE DETERMINATION; NCD;

AMERICAN HEART ASSOCIATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; CARDIOVASCULAR DISEASES; GUIDELINE ADHERENCE; HUMANS; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 84891750126     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.016     Document Type: Review

References (15)

1. Methodology Manual and Policies from the ACCF/AHA Task Force on Practice Guidelines. June 2010. Available at: http://assets.cardiosource.com/Methodology- Manual-for-ACC-AHA-Writing-Committees.pdf. Accessed May 28, 2013.
2. C.M. Tracy, A.E. Epstein, and D. Darbar et al. 2102 ACCF/AHA/HRS focused update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 1297 1313
3. A.M. Russo, R.F. Stainback, and S.R. Bailey et al. ACCF/HRS/AHA/ASE/HFSA/ SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy J Am Coll Cardiol 61 2013 1318 1368
4. R.C. Hendel, M.R. Patel, and J.M. Allen et al. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force J Am Coll Cardiol 61 2013 1305 1317
5. Report to the Congress: Medicare Payment Policy. Appendix B: An Introduction to How Medicare Makes Decisions. March 2003. Available at: http://www.medpac.gov/publications%5Ccongressional-reports%5CMar03-AppB.pdf. Accessed May 28, 2013.
6. National Coverage Determination (NCD) for Implantable Automatic Defibrillators (20.4). Medicare National Coverage Determinations (NCD) Manual. Publication 100-103. January 1, 2005. Centers for Medicare & Medicaid Services. Available at: http://www.cms.gov/medicare-coverage-database/details/ ncd-details.aspx?NCDId=110&ncdver=3&IsPopup=y&NCAId=102&NcaName= Implantable+Defibrillators+-+Clinical+Trials&bc=AAAAAAAAIAAA&. Accessed May 28, 2013.
7. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
8. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
9. A.E. Buxton, K.L. Lee, and L. DiCarlo et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death N Engl J Med 342 2000 1937 1945
10. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
11. J.S. Steinberg, and S. Mittal The federal audit of implantable cardioverter defibrillator implants J Am Coll Cardiol 59 2012 1270 1274
12. Department of Justice ICD Investigation Medical Review Guidelines/Resolution Model. Available at: http://www.modernhealthcare.com/ assets/pdf/CH81623830.PDF. Accessed May 28, 2013.
13. M.R. Patel, M.J. Wolk, J. Allen, G.J. Dehmer, and R.G. Brindis The privilege of self-regulation: the role of appropriate use criteria J Am Coll Cardiol 57 2011 1557 1559
14. A.E. Epstein, W.T. Abraham, and N. Bianco et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction J Am Coll Cardiol 62 2013 2000 2007
15. Advanced Beneficiary Notice of Non-coverage: Part A and Part B. Third edition. May 2012. Centers for Medicare & Medicaid Services. Available at: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/ MLNProducts/downloads/abn-booklet-icn006266.pdf. Accessed May 28, 2013.